Skip to content

EBIT at other companies

Bausch + Lomb logo
Bausch + LombBLCO
$33M+140%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-$93.34M-46.0%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$950M-444%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
-$6.12M+76.7%
AbbVie logo
AbbVieABBV
Viatris logo
ViatrisVTRS

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.59B+38.4%
Enterprise value$1.81B+13.8%
P/S5.9×+0.5×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Calculated from Harrow’s reported figures.

The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harrow's EBIT?
Harrow (HROW) reported EBIT of -$22.08M in Q1 2026.
How has Harrow's EBIT changed year-over-year?
Harrow's EBIT decreased by 96.6% year-over-year, from -$11.23M to -$22.08M.
What is the long-term trend for Harrow's EBIT?
Over 4 years (2021 to 2025), Harrow's EBIT has grown at a 97.8% compound annual growth rate (CAGR), from -$1.99M to $30.52M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.